Targeting Thymine Glycosylase Kills p53-Deficient Cancer Cells
In a groundbreaking study, researchers have unveiled the intricate role of thymine DNA glycosylase (TDG) in the realm of cancer ...
Tag: synthetic lethality in cancer
Curcumin and PARP Inhibitors: Synergistic Healing Unveiled
In the relentless pursuit of more effective cancer therapies, a promising synergy has emerged from an unlikely duo: curcumin, the ...
Optimized Tumor Therapy: Phase I Trial of Gapped Scheduling
In a groundbreaking development that could redefine cancer therapy, researchers have unveiled a novel approach to delivering topoisomerase I (top1) ...
CRISPR Screens Reveal GATOR1 as Tumor Suppressor
In a groundbreaking advance that reshapes our understanding of cancer biology, a team of researchers has successfully leveraged genome-wide in ...
Breakthrough First-in-Class Covalent Werner Helicase Inhibitor Demonstrates Clinical Proof-of-Concept in Phase I Trial
In a landmark development in the field of oncology and targeted cancer therapies, researchers at The University of Texas MD ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!